PURCHASE AGREEMENT Dated as of May 16, 2005 between AVANT IMMUNOTHERAPEUTICS, INC. and PRF VACCINE HOLDINGS LLCPurchase Agreement • May 18th, 2005 • Avant Immunotherapeutics Inc • In vitro & in vivo diagnostic substances • New York
PURCHASE AGREEMENT (as amended, supplemented or otherwise modified from time to time, this “Agreement”) is made and entered into as of May 16, 2005 by and among AVANT Immunotherapeutics, Inc., a Delaware corporation, and PRF Vaccine Holdings LLC, a Delaware limited liability company (“PRF”), an Affiliate of Paul Royalty Fund II, L.P., a Delaware limited partnership.
